Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-23

FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Montelukast Sodium from Lannett Company, Inc., adding regulatory approval for an additional generic Montelukast prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)